Hofsø Kristin, Bjordal Kristin, Diep Lien My, Rustøen Tone
Centre for Shared Decision Making and Collaborative Research, Oslo University Hospital, Rikshospitalet, Postboks 4950 Nydalen, 0424, Oslo, Norway,
Qual Life Res. 2014 Dec;23(10):2769-77. doi: 10.1007/s11136-014-0736-2. Epub 2014 Jun 21.
The purpose of this longitudinal study was to investigate quality of life (QOL) before, during, and after the course of radiotherapy (RT) and to identify risk factors for diminished QOL in women with breast cancer.
Patients (N = 188) completed the short-form 12 (SF-12), the Karnofsky Performance Status Scale, Memorial Symptom Assessment Scale, and the Self-Administrated Comorbidity Questionnaire 1 week prior to the start of RT. To assess changes in QOL, patients also completed the SF-12 1, 2, 3, and 6 months after the baseline. A random-intercept and slope model (mixed model) for each patient was used to estimate linear trends for the mental component score and physical component score of QOL (five time points for each patient). Descriptive statistics were used to analyze demographic and clinical characteristics.
The physical component score (PCS) did not change significantly (p = 0.078) during the course of RT in women with breast cancer. An increase in the number of symptoms and a higher comorbidity profile was negatively related to the PCS. The mental component score (MCS) did not change from the start of RT until the 2-month assessment, but increased significantly after 2 months (p = 0.044). An increase in the number of symptoms was negatively related to the MCS.
The MCS and PCS of QOL remained stable at a diminished level except for the MCS which improved between 2 and 6 months after the start of RT. The total number of symptoms was the only variable that was negatively associated with both component scores (MCS and PCS) during the 6 months.
本纵向研究旨在调查乳腺癌女性在放疗疗程前、疗程中和疗程后的生活质量(QOL),并确定生活质量下降的风险因素。
患者(N = 188)在放疗开始前1周完成了简短健康调查问卷12项版(SF - 12)、卡氏功能状态量表、纪念症状评估量表和自我管理共病问卷。为评估生活质量的变化,患者还在基线后的1、2、3和6个月完成了SF - 12。对每位患者使用随机截距和斜率模型(混合模型)来估计生活质量的心理成分得分和身体成分得分的线性趋势(每位患者五个时间点)。描述性统计用于分析人口统计学和临床特征。
乳腺癌女性在放疗疗程中身体成分得分(PCS)无显著变化(p = 0.078)。症状数量增加和较高的共病情况与PCS呈负相关。心理成分得分(MCS)从放疗开始到2个月评估时没有变化,但在2个月后显著增加(p = 0.044)。症状数量增加与MCS呈负相关。
生活质量的MCS和PCS在放疗开始后的2至6个月有所改善,除此之外,生活质量的MCS和PCS在降低水平上保持稳定。在6个月期间,症状总数是与两个成分得分(MCS和PCS)均呈负相关的唯一变量。